NCT01777932View on ClinicalTrials.gov

AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Breast Cancer
Trial Locations (32)

1031

Budapest

1076

Budapest

1082

Budapest

1088

Budapest

1097

Budapest

1106

Budapest

1115

Budapest

1122

Budapest

1125

Budapest

1135

Budapest

1145

Budapest

2143

Kistarcsa

2800

Tatabánya

3100

Salgótarján

3300

Eger

3526

Miskolc

4012

Debrecen

4400

Nyíregyháza

5004

Szolnok

5700

Gyula

6000

Kecskemét

6600

Szentes

6720

Szeged

7100

Szekszárd

7400

Kaposvár

7624

Pécs

8000

Székesfehérvár

8200

Veszprém

8900

Zalaegerszeg

9023

Győr

9700

Szombathely

H-4031

Debrecen

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01777932 - AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter